BridgeBio Pharma, Inc. (BIT:1BBIO)

Italy · Delayed Price · Currency is EUR

55.18

-1.28 (-2.27%)

At close: Mar 3, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Identifying and Advancing Transformative Medicines to Treat Patients	502.08M	221.90M	9.30M	77.65M	69.72M
Identifying and Advancing Transformative Medicines to Treat Patients Growth	126.26%	2285.27%	-88.02%	11.38%	745.14%
Total	502.08M	221.90M	9.30M	77.65M	69.72M
Total Growth	126.26%	2285.27%	-88.02%	11.38%	745.14%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	362.50M	13.31M	7.90M	-	69.72M
United States Growth	2622.66%	68.57%	-	-	745.14%
Europe, Middle East, and Africa (EMEA)	127.03M	132.03M	55.82K	-	-
Europe, Middle East, and Africa (EMEA) Growth	-3.79%	236439.63%	-	-	-
Asia-Pacific (APAC)	12.55M	76.56M	1.35M	-	-
Asia-Pacific (APAC) Growth	-83.60%	5575.31%	-	-	-
North America	-	-	-	76.79M	-
Total	502.08M	221.90M	9.30M	76.79M	69.72M
Total Growth	126.26%	2285.27%	-87.89%	10.15%	745.14%

Source: S&P Global Market Intelligence.